Ling et al. confirmed these conclusions in 2015, when they also showed that urine CD80 levels were higher in patients with active MCD compared to patients with MCD in remission, patients with FSGS or other glomerulopathies, and healthy controls. Here, CD80 is linked to focal segmental glomerulosclerosis.